Exelixis
EXEL
#1458
Rank
ยฃ11.20 B
Marketcap
ยฃ45.24
Share price
1.42%
Change (1 day)
56.62%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: ยฃ11.20 Billion

As of October 2026 Exelixis has a market cap of ยฃ11.20 Billion. This makes Exelixis the world's 1458th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ11.20 B21.26%
2025ยฃ9.24 B20.13%
2024ยฃ7.69 B31.39%
2023ยฃ5.85 B36.92%
2022ยฃ4.27 B-0.19%
2021ยฃ4.28 B-6.2%
2020ยฃ4.56 B11.89%
2019ยฃ4.08 B-12.14%
2018ยฃ4.64 B-30.17%
2017ยฃ6.65 B89.96%
2016ยฃ3.50 B303.8%
2015ยฃ0.86 B378.84%
2014ยฃ0.18 B-73.58%
2013ยฃ0.68 B32.03%
2012ยฃ0.51 B25.77%
2011ยฃ0.41 B-28.95%
2010ยฃ0.58 B18.25%
2009ยฃ0.49 B35.89%
2008ยฃ0.36 B-20.51%
2007ยฃ0.45 B3.17%
2006ยฃ0.44 B-3.19%
2005ยฃ0.45 B22.77%
2004ยฃ0.37 B32.07%
2003ยฃ0.28 B-5.17%
2002ยฃ0.29 B-53.96%
2001ยฃ0.64 B40.55%
2000ยฃ0.45 B

End of Day market cap according to different sources

On Oct 9th, 2026 the market cap of Exelixis was reported to be:

ยฃ11.20 Billion
by Nasdaq info icon info icon
ยฃ11.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ476.11 B 4,147.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ121.80 B 986.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ169.49 B 1,412.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ72.55 B 547.33%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ271.45 B 2,321.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ91.25 B 714.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ70.40 B 528.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
ยฃ1.23 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
ยฃ0.39 B-96.48%๐Ÿ‡บ๐Ÿ‡ธ USA